Literature DB >> 9920765

Molecular and functional evidence for calcineurin-A alpha and beta isoforms in the osteoclast: novel insights into cyclosporin A action on bone resorption.

E M Awumey1, B S Moonga, B R Sodam, A P Koval, O A Adebanjo, M Kumegawa, M Zaidi, S Epstein.   

Abstract

We provide the first molecular evidence for the presence of a functional serine/threonine phosphatase, calcineurin-A (CN-A), in the osteoclast. Polymerase chain reaction (PCR) of an osteoclast cDNA library, together with restriction mapping, revealed two isoform sequences, alpha and beta. We then examined the functionality of the detected CN-A by assessing the effect of a classical antagonist, cyclosporin A (CsA), in the osteoclast resorption (pit) assay. CsA (0.1 and 1 microg ml-1) potently inhibited bone resorption. The presence of lymphocytes, with or without prior exposure to CsA in vivo, failed to reverse the CsA-induced resorption-inhibition. Expectedly, CsA had no direct effect on cytosolic Ca2+ levels in fura-2-loaded osteoclasts. These studies are a prelude to further investigations into the possible role of CN-A in osteoclast regulation. Finally, mechanistic studies on the bone effects of CsA, a widely used immunosupressant, should proceed from these observations. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9920765     DOI: 10.1006/bbrc.1998.9785

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Schizophrenia and vitamin D related genes could have been subject to latitude-driven adaptation.

Authors:  Roberto Amato; Michele Pinelli; Antonella Monticelli; Gennaro Miele; Sergio Cocozza
Journal:  BMC Evol Biol       Date:  2010-11-11       Impact factor: 3.260

2.  Calcineurin promotes proliferation, migration, and invasion of small cell lung cancer.

Authors:  Yan Liu; Ye Zhang; Jie Min; Li-Li Liu; Ning-Qiang Ma; Ying-Ming Feng; Dong Liu; Ping-zhong Wang; De-Dong Huang; Yan Zhuang; He-Long Zhang
Journal:  Tumour Biol       Date:  2010-04-27

3.  Calcineurin regulates bone formation by the osteoblast.

Authors:  Li Sun; Harry C Blair; Yuanzhen Peng; Neeha Zaidi; Olugbenga A Adebanjo; Xue Bin Wu; Xing Yao Wu; Jameel Iqbal; Solomon Epstein; Etsuko Abe; Baljit S Moonga; Mone Zaidi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-14       Impact factor: 11.205

Review 4.  CYP3A4 is a crosslink between vitamin D and calcineurin inhibitors in solid organ transplant recipients: implications for bone health.

Authors:  A Prytuła; K Cransberg; A Raes
Journal:  Pharmacogenomics J       Date:  2017-04-18       Impact factor: 3.550

5.  Calcineurin plays an important role in the shell formation of pearl oyster (Pinctada fucata).

Authors:  Changzhong Li; Yilin Hu; Jian Liang; Yawei Kong; Jing Huang; Qiaoli Feng; Shuo Li; Guiyou Zhang; Liping Xie; Rongqing Zhang
Journal:  Mar Biotechnol (NY)       Date:  2009-07-11       Impact factor: 3.619

Review 6.  What is the impact of immunosuppressive treatment on the post-transplant renal osteopathy?

Authors:  Kristina Blaslov; Lea Katalinic; Petar Kes; Goce Spasovski; Ruzica Smalcelj; Nikolina Basic-Jukic
Journal:  Int Urol Nephrol       Date:  2013-11-12       Impact factor: 2.370

Review 7.  Potential role of calcineurin in pathogenic conditions.

Authors:  Khaliq Kurji; Rajendra K Sharma
Journal:  Mol Cell Biochem       Date:  2009-12-05       Impact factor: 3.396

8.  Dynamin participates in focal extracellular matrix degradation by invasive cells.

Authors:  Massimiliano Baldassarre; Arsenio Pompeo; Galina Beznoussenko; Claudia Castaldi; Salvatore Cortellino; Mark A McNiven; Alberto Luini; Roberto Buccione
Journal:  Mol Biol Cell       Date:  2003-03       Impact factor: 4.138

Review 9.  Osteoporosis after solid organ and bone marrow transplantation.

Authors:  Adi Cohen; Elizabeth Shane
Journal:  Osteoporos Int       Date:  2003-08-08       Impact factor: 4.507

10.  Elevated incidence of fractures in solid-organ transplant recipients on glucocorticoid-sparing immunosuppressive regimens.

Authors:  B J Edwards; A Desai; J Tsai; H Du; G R Edwards; A D Bunta; A Hahr; M Abecassis; S Sprague
Journal:  J Osteoporos       Date:  2011-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.